ulipristal acetate sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - ulipristaal - õhukese polümeerikattega tablett - 30mg 1tk
seasonique õhukese polümeerikattega tablett
zentiva k.s. - levonorgestreel+etünüülöstradiool - õhukese polümeerikattega tablett - 0,15mg+0,03mg/0+0,01mg 84tk / 7tk
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastilised ained - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - muud närvisüsteemi ravimid - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
fentanyl kalceks süstelahus
ideal trade links uab - fentanüül - süstelahus - 50mcg 1ml 10ml 10tk
fentanyl kalceks süstelahus
ideal trade links uab - fentanüül - süstelahus - 50mcg 1ml 10ml 10tk
amoxicillin/clavulanic acid sandoz süste-/infusioonilahuse pulber
sandoz pharmaceuticals d.d. - amoksitsilliin+klavulaanhape - süste-/infusioonilahuse pulber - 1000mg+200mg 5tk; 1000mg+200mg 1tk
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukeemia, müeloid - antineoplastilised ained - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
labella tablett
exeltis baltics uab - levonorgestreel - tablett - 1,5mg 1tk